% | $
Quotes you view appear here for quick access.

Synergy Pharmaceuticals, Inc. Message Board

  • ding_king2000 ding_king2000 Jan 25, 2013 9:38 PM Flag

    No energy for Synergy

    No energy for Synergy
    Shares for Synergy Pharmaceuticals (NASDAQ: SGYP ) were down over 8% this week on the heels of a 9% fall last week. What's going on?

    Synergy started the year off on a good note with positive results from its phase 2b/3 trial of plecanatide. The experimental drug for chronic idiopathic constipation met its primary and key secondary endpoints in the study. That news helped drive shares higher by 25%. But the stock has gone steadily downward since Jan. 17.

    It's probably merely a coincidence that Synergy announced the closing of its merger with Callisto Pharmaceuticals on that date, especially since the deal has been in the works for months. The decline might be related to worries that Synergy won't be able to find a partner to bring plecanatide to market. Whatever the reason, shares have certainly lost the energy from earlier in January.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.55+0.01(+0.28%)May 25 4:00 PMEDT